Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of the National Cancer Institute|March 20, 2019
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast CancerRim S Kim, Nan Song, Patrick G Gavin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2020
Neratinib-Plus-Cetuximab in Quadruple-WT (<i>KRAS, NRAS, BRAF, PIK3CA</i>) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib StudySamuel A Jacobs, James J Lee, Thomas J George, et al.Breast Cancer Research : BCR|December 5, 2019
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancerSamuel A Jacobs, André Robidoux, Jame Abraham, et al.Breast Cancer Research : BCR|January 24, 2020
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancerSamuel A Jacobs, André Robidoux, Jame Abraham, et al.Journal of the National Cancer Institute|November 23, 2013
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31Katherine L Pogue-Geile, Chungyeul Kim, Jong-Hyeon Jeong, et al.Pageof 3